Metabolic derivatives of numerous microorganisms inhabiting the human gut can participate
in physiological activities and immune status of the lungs through the gut-lung axis. The …

Recent years have seen an outstanding growth in the understanding of connections
between diet-induced obesity, dysbiosis and alterations in the tumor microenvironment. Now …

Liquid biopsies have emerged as a promising tool for the detection of metastases as well as
local and regional recurrence in lung cancer. Liquid biopsy tests involve analyzing a …

Intestinal flora affects the maturation of the host immune system, serves as a biomarker and
efficacy predictor in the immunotherapy of several cancers, and has an important role in the …

Immunotherapy has emerged as a robust approach against cancer, yet its efficacy has
varied among individuals, accompanied by the occurrence of immune-related adverse …

Background: The promise of immune checkpoint inhibitors (ICIs) therapy in cancer treatment
is tempered by the occurrence of immune-related adverse events (irAEs). Many patients …

Although immune checkpoint inhibitors (ICIs) have greatly improved the prognosis of some
cancer patients, the majority still fail to respond adequately, and the available biomarkers …

The intestinal microbiota is considered to be a forgotten organ in human health and disease.
It maintains intestinal homeostasis through various complex mechanisms. A significant body …

The emergence of immune checkpoint inhibitors (ICIs) has heralded a transformative era in
the therapeutic landscape of non‐small cell lung cancer (NSCLC). While ICIs have …

We delve into the critical role of the gut microbiota and its metabolites in the pathogenesis
and progression of hepatobiliary and pancreatic (HBP) cancers, illuminating an urgent need …